Evidence map›Paper›PMID 30069054›Full record

ArticleNature2018

CRISPR-guided DNA polymerases enable diversification of all nucleotides in a tunable window.

Shakked O Halperin, Connor J Tou, Eric B Wong, Cyrus Modavi, David V Schaffer, John E Dueber

Abstract read
PubMed Publisher
In one paragraph

Article in Nature, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 175 papers.

0numbers the graph read from it
0cells of the map it votes in
175citing papers in PubMed
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

175 citing papers in PubMed, 328 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Wheat's Up with CRISPR-Cas-Current Advances, Obstacles and Perspectives.International journal of molecular sciences · 2026
    Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

115 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Shakked O HalperinDepartment of Bioengineering, University of California, Berkeley, Berkeley, CA, USA.
Connor J TouDepartment of Bioengineering, University of California, Berkeley, Berkeley, CA, USA.
Eric B WongDepartment of Bioengineering, University of California, Berkeley, Berkeley, CA, USA.
Cyrus ModaviDepartment of Bioengineering, University of California, Berkeley, Berkeley, CA, USA.
David V SchafferDepartment of Bioengineering, University of California, Berkeley, Berkeley, CA, USA. schaffer@berkeley.edu.
John E DueberDepartment of Bioengineering, University of California, Berkeley, Berkeley, CA, USA. jdueber@berkeley.edu.
University of California, Berkeley · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The capacity to diversify genetic codes advances our ability to understand and engineer biological systems

Indexed as

CRISPR-Cas SystemsDirected Molecular EvolutionDNA-Directed DNA PolymeraseDrug Resistance, MicrobialEscherichia coliEscherichia coli ProteinsGene EditingMutagenesis, Site-DirectedMutationMutation RateNucleotidesRibosomal ProteinsSpectinomycinDNA-Directed DNA PolymeraseEscherichia coli ProteinsNucleotidesRibosomal ProteinsRpsF protein, E coliSpectinomycin

Identifiers

PMID30069054
OpenAlexW2887001543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.